Brought to you by 
FGH Biotech gets IP from Kyoto U. and TUAT
08 Mar 2017
Executive Summary
Kyoto University (KU) and Tokyo University of Agriculture and Technology (TUAT) licensed FGH Biotech Inc. exclusive global rights to patents and technology for use in developing and commercializing vitamin D and derivatives.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Nutraceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
FGH Biotech gets IP from Kyoto U. and TUAT
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice